Samsung Biologics, Foreign Investors Net Buy 59,932 Shares... Stock Price Up 3.38%
As of 2:33 PM on the 13th, Samsung Biologics is trading at 612,000 KRW, up 3.38% from the previous day. This marks a 27.9% increase compared to April 9. Samsung Biologics is known as the holding company for Samsung Group's bio business.
Today, foreigners have a provisional net purchase of 59,932 shares of Samsung Biologics, and institutions have a net purchase of 15,000 shares. Over the past five days, individual investors have net sold 133,436 shares, while foreigners and institutions have net bought 124,654 shares and 55,976 shares, respectively.
[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
